迈克尔Teitell

Following an extensive national search, Michael 泰特尔，医学博士，博士 was appointed as the director of the UCLA Health Jonsson Comprehensive 癌症中心 on August 8, 2017. Teitell holds the Latta Endowed Chair in Pathology and is a full professor in the Departments of Pathology and Laboratory Medicine, with joint appointments in the Departments of Pediatrics and Bioengineering. He serves as Physician and Chief of the Division of Pediatric and Neonatal Pathology and he has been a member of the cancer center since 1999. Teitell is also a member of the Molecular Biology Institute, the Broad Center of Regenerative Medicine and Stem Cell Research, 艾滋病研究所, and the California NanoSystems Institute at UCLA.

Teitell received concurrent BS and MS degrees from the UCLA College Honors Program as a Departmental Scholar in Chemistry and Biochemistry in 1985. He earned combined MD and PhD degrees in the UCLA Medical Scientist 培训 Program in 1993 under the mentorship of Dr. 米切尔Kronenberg, current President and Chief Scientific Officer of the La Jolla Institute for Allergy and Immunology. Teitell was a resident and clinical instructor in anatomic pathology at Brigham and Women's Hospital and Harvard Medical School (1993–1995), and during this time he was also a research associate with Dr. 理查德•布伦伯格. He was a resident in clinical pathology at UCSF and a post-doctoral researcher with Dr. 乔·格雷(1995-1997). Teitell held a joint appointment at Children's Hospital of Los Angeles as a pediatric pathology fellow and at UCLA as a clinical instructor in pathology (1997–1999).

经委员会认证的解剖学, 临床和儿科病理学, Teitell joined the UCLA faculty as an assistant professor in 1999, and rose to the rank of full professor by 2008. He is director of the David Geffen 医学院 Cancer Research Theme, co-director of the UCLA Tumor Immunology 培训 Program, co-director of the Broad Stem Cell Research Center Bioengineering Core, and an associate director of the UCLA-Caltech Medical Scientist 培训 Program (MD, 博士学位). 在皇冠hga025大学洛杉矶分校, he serves as the NCAA Faculty Athletics Representative for Intercollegiate Athletics and holds posts on the Mountain Pacific Sports Federation (Chair, 2014–), Pac-12 Conference Diversity Leadership Committee (Chair, 2016–), and Pac-12 Conference Woman of the Year Nominating Committee (Chair, 2016–). Teitell is also President of the UCLA Health Jonsson Comprehensive 癌症中心 Foundation, which in the past five years has raised over $77 million.

Teitell's previous professional and administrative experience includes appointments to the California Cancer Research Coordinating Committee (Chair, 2008), the UCLA Academic Senate Intercollegiate Athletics Committee (Chair, 2008–2014, 当然2014 -), the NIH 癌症中心 Site Visit Team and NIH Cancer Genetics Study Section (2004–2010) and the NIH Provocative Questions Review Panel (Chair, 2015). Teitell has also organized national and international meetings, including the 2007 CNSI/CNBI Joint Meeting on NanoBiology, the 2007 ISCBM Conference on Development and Stem Cells, and the 2014 Cell Press Symposium on Stem Cell Energy Metabolism. He is a member of the American Association of Immunologists, the American Association for Cancer Research, 生物物理学会, and the American Society for Biochemistry and Molecular Biology.

A renowned molecular immunologist and biochemist, Teitell's research on the fundamental mechanisms of cancer formation and progression, particularly for B lymphocyte malignancies, has attained international acclaim. This led to projects in stem and cancer cell metabolism and the collaborative development of new approaches in cell engineering and response detection. Teitell is the recipient of the Stohlman Memorial Scholar Award from the Leukemia and Lymphoma Society of America, 玛格丽特E号. Early Medical Research Trust Award, the FOCIS/Millenium Pharmaceuticals Award for Genomics Research, and he was elected to the American Society of Clinical Investigators (ASCI) in 2004 and to the Association of American Physicians (AAP) in 2017.